JP2003518482A5 - - Google Patents

Download PDF

Info

Publication number
JP2003518482A5
JP2003518482A5 JP2001548085A JP2001548085A JP2003518482A5 JP 2003518482 A5 JP2003518482 A5 JP 2003518482A5 JP 2001548085 A JP2001548085 A JP 2001548085A JP 2001548085 A JP2001548085 A JP 2001548085A JP 2003518482 A5 JP2003518482 A5 JP 2003518482A5
Authority
JP
Japan
Prior art keywords
poly
hydroxy
elastomer
alkylene oxide
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001548085A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003518482A (ja
JP4895150B2 (ja
Filing date
Publication date
Priority claimed from US09/472,126 external-priority patent/US6476079B1/en
Application filed filed Critical
Publication of JP2003518482A publication Critical patent/JP2003518482A/ja
Publication of JP2003518482A5 publication Critical patent/JP2003518482A5/ja
Application granted granted Critical
Publication of JP4895150B2 publication Critical patent/JP4895150B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2001548085A 1999-12-23 2000-11-21 抗黄体ホルモン特性を有する薬物を送達するための器具 Expired - Fee Related JP4895150B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/472,126 1999-12-23
US09/472,126 US6476079B1 (en) 1999-12-23 1999-12-23 Devices for the delivery of drugs having antiprogestinic properties
PCT/FI2000/001013 WO2001047490A1 (en) 1999-12-23 2000-11-21 Devices for the delivery of drugs having antiprogestinic properties

Publications (3)

Publication Number Publication Date
JP2003518482A JP2003518482A (ja) 2003-06-10
JP2003518482A5 true JP2003518482A5 (cg-RX-API-DMAC7.html) 2010-11-18
JP4895150B2 JP4895150B2 (ja) 2012-03-14

Family

ID=23874296

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001548085A Expired - Fee Related JP4895150B2 (ja) 1999-12-23 2000-11-21 抗黄体ホルモン特性を有する薬物を送達するための器具

Country Status (31)

Country Link
US (1) US6476079B1 (cg-RX-API-DMAC7.html)
EP (1) EP1239829B1 (cg-RX-API-DMAC7.html)
JP (1) JP4895150B2 (cg-RX-API-DMAC7.html)
KR (1) KR100850548B1 (cg-RX-API-DMAC7.html)
CN (1) CN100346772C (cg-RX-API-DMAC7.html)
AR (1) AR026647A1 (cg-RX-API-DMAC7.html)
AT (1) ATE401859T1 (cg-RX-API-DMAC7.html)
AU (1) AU781555B2 (cg-RX-API-DMAC7.html)
BR (1) BR0016697A (cg-RX-API-DMAC7.html)
CA (1) CA2395226C (cg-RX-API-DMAC7.html)
CO (1) CO5261571A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ301865B6 (cg-RX-API-DMAC7.html)
DE (2) DE60039626D1 (cg-RX-API-DMAC7.html)
DK (1) DK1239829T3 (cg-RX-API-DMAC7.html)
EE (1) EE05123B1 (cg-RX-API-DMAC7.html)
ES (1) ES2310526T3 (cg-RX-API-DMAC7.html)
HK (1) HK1047235B (cg-RX-API-DMAC7.html)
HU (1) HU229438B1 (cg-RX-API-DMAC7.html)
IL (2) IL149663A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA02006174A (cg-RX-API-DMAC7.html)
NO (1) NO332261B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ519876A (cg-RX-API-DMAC7.html)
PE (1) PE20010801A1 (cg-RX-API-DMAC7.html)
PL (1) PL201216B1 (cg-RX-API-DMAC7.html)
PT (1) PT1239829E (cg-RX-API-DMAC7.html)
RU (1) RU2228170C2 (cg-RX-API-DMAC7.html)
SK (1) SK287229B6 (cg-RX-API-DMAC7.html)
TW (1) TWI248367B (cg-RX-API-DMAC7.html)
UA (1) UA70401C2 (cg-RX-API-DMAC7.html)
WO (1) WO2001047490A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200203620B (cg-RX-API-DMAC7.html)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6887948B2 (en) * 1998-06-30 2005-05-03 Schering Oy Method for preparing a siloxane-based elastomer composition
US6794464B2 (en) 1998-06-30 2004-09-21 Schering Oy Membrane or matrix for controlling the permeation rate of drugs
WO2002032433A1 (en) * 2000-10-20 2002-04-25 Leiras Oy Drug delivery system
CA2457979A1 (en) * 2001-08-31 2003-03-06 Schering Oy A delivery system
EP1438942A1 (en) * 2003-01-17 2004-07-21 Schering Oy An otorhinological drug delivery device
SI1696822T1 (sl) * 2003-11-13 2010-07-30 Psivida Inc Injektibilen implantat z zadržanim sproščanjem, ki ima bioerodibilno matično jedro in bioerodibilno kožo
RU2283637C1 (ru) * 2005-03-22 2006-09-20 Общество с ограниченной ответственностью "Производственно-коммерческая фирма "Две линии" Пластырь
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
KR101377900B1 (ko) 2005-10-13 2014-03-27 신세스 게엠바하 약물-함침 용기
US20070149916A1 (en) * 2005-12-22 2007-06-28 Alza Corporation Dry matrices as drug reservoirs in electrotransport applications
EP1862468A1 (de) * 2006-06-02 2007-12-05 Bayer Schering Pharma Aktiengesellschaft Kristallines 11beta-(4-Acetylphenyl)-20,20,21,21,21-pentafluor-17-hydroxy-19-nor-17alpha-pregna-4,9-dien-3-on
US20080261929A1 (en) * 2007-04-23 2008-10-23 Jens Hoffmann Combination of progesterone-receptor antagonist together with an aromatase inhibitor for use in brca mediated diseases
DE102007032468A1 (de) * 2007-07-10 2009-01-15 Brätter, Christian, Dr. Transdermale Therapeutische Systeme, welche den Wirkstoff Anastrozol enthalten
AR066166A1 (es) * 2007-09-21 2009-07-29 Organon Nv Sistema de suministro de droga
EP2057972A1 (en) * 2007-11-07 2009-05-13 N.V. Organon Intrauterine deposit
TW200927141A (en) * 2007-11-22 2009-07-01 Bayer Schering Pharma Oy Vaginal delivery system
US11992431B2 (en) 2008-09-17 2024-05-28 Bayer Oy Inserter
FI20080523A0 (fi) 2008-09-17 2008-09-17 Bayer Schering Pharma Oy Insertteri
WO2010031902A1 (en) 2008-09-17 2010-03-25 Bayer Schering Pharma Oy An inserter
CA2738880A1 (en) * 2008-11-06 2010-05-14 Novo Nordisk A/S Electronically assisted drug delivery device
US8822610B2 (en) 2008-12-22 2014-09-02 ATRP Solutions, Inc. Control over controlled radical polymerization processes
US8815971B2 (en) 2008-12-22 2014-08-26 ATRP Solutions, Inc. Control over controlled radical polymerization processes
US8173750B2 (en) 2009-04-23 2012-05-08 ATRP Solutions, Inc. Star macromolecules for personal and home care
US9783628B2 (en) 2009-04-23 2017-10-10 ATRP Solutions, Inc. Dual-mechanism thickening agents for hydraulic fracturing fluids
US8569421B2 (en) 2009-04-23 2013-10-29 ATRP Solutions, Inc. Star macromolecules for personal and home care
US8568374B2 (en) * 2009-05-04 2013-10-29 Merck Sharp & Dohme B.V. Intrauterine system
DE102009034366A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylenoxyalkylenaryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034367A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034362A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034368A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylenphenyl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034525A1 (de) 2009-07-21 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034526A1 (de) 2009-07-21 2011-02-10 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102010007719A1 (de) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesteronrezeptorantagonisten
DE102010007722A1 (de) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesteronrezeptorantagonisten
JP5894143B2 (ja) * 2010-03-22 2016-03-23 リプロス セラピューティクス インコーポレイテッド 抗黄体ホルモンの無毒送達のための組成物および方法
US9587064B2 (en) 2010-12-08 2017-03-07 ATRP Solutions, Inc. Salt-tolerant star macromolecules
DE102011004899A1 (de) 2011-03-01 2012-09-06 Bayer Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
US9381193B2 (en) * 2011-04-01 2016-07-05 Washington University Contraceptive methods and compositions
BR112014001450A2 (pt) * 2011-07-20 2017-07-18 F Kiser Patrick dispositivos intravaginais para distribuição de droga
TWI590843B (zh) 2011-12-28 2017-07-11 信迪思有限公司 膜及其製造方法
CA2882832C (en) 2012-08-30 2021-08-24 ATRP Solutions, Inc. Dual mechanism thickening agents for hydraulic fracturing fluids
EP2951220B1 (en) 2013-02-04 2020-11-25 Pilot Polymer Technologies, Inc. Salt-tolerant star macromolecules
EP2953678B1 (en) 2013-02-06 2020-03-25 Sillender, Mark Therapeutic substance transfer catheter
AU2014214538B2 (en) 2013-02-06 2018-11-15 Mark SILLENDER Embryo transfer catheter and method
WO2014160305A1 (en) * 2013-03-14 2014-10-02 Albany Molecular Research, Inc. Ligand-therapeutic agent conjugates and silicon-based linkers
ES2708351T3 (es) 2013-04-11 2019-04-09 Bayer Pharma AG Forma de dosificación de un antagonista del receptor de progesterona
JP6456935B2 (ja) 2013-06-21 2019-01-23 デピュイ・シンセス・プロダクツ・インコーポレイテッド フィルム及び製造方法
WO2015023811A2 (en) 2013-08-16 2015-02-19 The J. David Gladstone Institutes Compositions and methods for identifying latently infected cells
EP2982352B1 (en) * 2014-06-28 2018-10-03 Laboratorios Andrómaco S.A. Cervical pessary containing progesterone for prolonged, sustained and continuous release, used to prevent premature birth
JP6689210B2 (ja) 2014-07-03 2020-04-28 パイロット ポリマー テクノロジーズ， インク． 界面活性剤相溶性星形高分子
EP3206751A4 (en) 2014-10-14 2018-06-13 The J. David Gladstone Institutes Compositions and methods for reactivating latent immunodeficiency virus
CN107406677A (zh) * 2015-03-05 2017-11-28 道康宁东丽株式会社 可固化有机聚硅氧烷组合物、其用途以及由该组合物制备的层合体
EP3294300B1 (en) * 2015-05-13 2024-12-18 Bayer Oy Long acting drug delivery device in form of an implant or iud comprising levonorgestrel and ethinylestradiol
CN106546705B (zh) * 2015-09-21 2020-03-17 上海复旦张江生物医药股份有限公司 一种脂质体药物体外释放的测试方法
CN106546706B (zh) * 2015-09-21 2020-03-17 上海复旦张江生物医药股份有限公司 pH梯度主动载药法制备的脂质体药物的体外释放测试方法
MX385367B (es) 2016-06-07 2025-03-18 The J David Gladstone Inst Esteres de acidos grasos de cadena media de beta-hidroxibutirato y butanodiol y composiciones y metodos para usar los mismos.
EP3542786A1 (en) * 2018-03-21 2019-09-25 ITF Research Pharma, S.L.U. Progesterone intravaginal devices
CA3087238A1 (en) 2018-05-24 2019-11-28 Celanese EVA Performance Polymers Corporation Implantable device for sustained release of a macromolecular drug compound
EP3840749B1 (en) 2018-08-22 2023-08-09 The J. David Gladstone Institutes, A Testamentary Trust Established under The Will of J. David Gladstone Compounds for treating cardiac valve disease
WO2020252305A1 (en) 2019-06-14 2020-12-17 The J. David Gladstone Institutes, A Testamentary Trust Establishe Under The Will Of J. David Gladstone Compositions and methods for treating an immunodeficiency virus infection with a therapeutic interfering particle
US10918649B2 (en) * 2019-06-21 2021-02-16 The Population Council, Inc. System for providing birth control
BR112023022439A2 (pt) 2021-04-26 2023-12-26 Celanese Eva Performance Polymers Llc Dispositivo implantável para liberação sustentada de um composto de fármaco macromolecular
TWI803052B (zh) * 2021-11-12 2023-05-21 佛教慈濟醫療財團法人 經皮遞送裝置及其使用及製造方法
US20230263724A1 (en) * 2022-02-22 2023-08-24 Celanese Eva Performance Polymers Llc Intravaginal Ring Device for the Delivery of Aromatase Inhibitor
CN119662025A (zh) * 2023-09-13 2025-03-21 沈阳药科大学 硅胶材料及其制备方法、硅胶管和埋植剂及其制备方法、应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3279996A (en) * 1962-08-28 1966-10-18 Jr David M Long Polysiloxane carrier for controlled release of drugs and other agents
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US3832252A (en) * 1970-09-29 1974-08-27 T Higuchi Method of making a drug-delivery device
JPS519003B1 (cg-RX-API-DMAC7.html) * 1970-11-07 1976-03-23
US3836560A (en) 1971-03-08 1974-09-17 Union Carbide Corp Organosilicone polymers
US4155991A (en) * 1974-10-18 1979-05-22 Schering Aktiengesellschaft Vaginal ring
US4323488A (en) * 1979-03-26 1982-04-06 Shin-Etsu Chemical Company Limited Method for the preparation of silicone-modified polyoxyalkylene polyethers and room temperature-curable compositions therewith
JPS60148560A (ja) * 1984-01-17 1985-08-05 富士システムズ株式会社 皮膚用封止材
US4600751A (en) * 1984-12-18 1986-07-15 Dow Corning Corporation Hydrophilic silicone-organic copolymer elastomers
CA1257727A (en) * 1984-12-18 1989-07-18 Chi-Long Lee Hydrophilic silicone-organic copolymer elastomers
GB8704755D0 (en) * 1987-02-28 1987-04-01 Dow Corning Ltd Pharmaceutical delivery device
US4951657A (en) * 1988-04-22 1990-08-28 Dow Corning Corporation Heat sealable membrane for transdermal drug release
EP0545002A1 (en) 1991-11-21 1993-06-09 Kose Corporation Silicone polymer, paste-like composition and water-in-oil type cosmetic composition comprising the same
FI95768C (fi) * 1993-06-17 1996-03-25 Leiras Oy Emättimensisäinen antosysteemi
US5660848A (en) * 1994-11-02 1997-08-26 The Population Council, Center For Biomedical Research Subdermally implantable device
US5521166A (en) * 1994-12-19 1996-05-28 Ortho Pharmaceitical Corporation Antiprogestin cyclophasic hormonal regimen
JP3201940B2 (ja) * 1995-09-12 2001-08-27 信越化学工業株式会社 硬化性シリコーンエラストマー組成物及びその製造方法
US5811487A (en) * 1996-12-16 1998-09-22 Dow Corning Corporation Thickening silicones with elastomeric silicone polyethers
US5889108A (en) 1997-06-02 1999-03-30 Dow Corning Corporation Thickening solvents with elastomeric silicone polyethers
US6013711A (en) 1997-06-18 2000-01-11 Ck Witco Corporation Hydrophilic polysiloxane compositions
FI103051B1 (fi) 1997-08-22 1999-04-15 Leiras Oy Uusia blokkikopolymeerejä ja niiden valmistus
FI107339B (fi) 1998-06-30 2001-07-13 Leiras Oy Lääkeaineiden läpäisynopeutta säätävä kalvo tai matriisi
US6063395A (en) * 1998-11-12 2000-05-16 Leiras Oy Drug delivery device especially for the delivery of progestins and estrogens

Similar Documents

Publication Publication Date Title
JP2003518482A5 (cg-RX-API-DMAC7.html)
RU2002119587A (ru) Устройство для доставки лекарственных средств, обладающих антипрогестиновыми свойствами
JP2004503634A5 (cg-RX-API-DMAC7.html)
JP2010509386A5 (cg-RX-API-DMAC7.html)
HRP20100366T1 (hr) Antagonisti receptora progesterona
IL142525A (en) Membrane or lattice for drug infiltration control
RU2010100334A (ru) ПРОИЗВОДНОЕ 17β-ЦИАНО-18А-ГОМО-19-НОР-АНДРОСТ-4-ЕНА, ЕГО ПРИМЕНЕНИЕ И ЛЕКАРСТВЕННЫЕ СРЕДСТВА, СОДЕРЖАЩИЕ ПРОИЗВОДНОЕ
ATE157372T1 (de) 14beta-h-, 14- und 15-en-11beta-aryl-4-estrene
EP1045006A3 (en) Silicone rubber composition
EA200501739A1 (ru) Композиция, содержащая антагонисты рецептора прогестерона и чистые антиэстрогены, предназначенные для профилактики и лечения гормонзависимых заболеваний
AU5627001A (en) Polyorganosiloxane mixtures for treating fiber materials
KR950031078A (ko) 생식 조절용 의약 조성물
JP2008247812A (ja) シリコーン組成物
JP2004510005A5 (cg-RX-API-DMAC7.html)
ATE397636T1 (de) Kombination von aminofunktionellen und acrylatfunktionellen polyorganosiloxanen
JP2001158854A5 (cg-RX-API-DMAC7.html)